|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,395.00 TWD | 0.00% |
|
+20.78% | +196.81% |
| 06-18 | PharmaEssentia Rebuffs Media Report Speculating Profit, Revenue for 2026 | MT |
| 06-11 | PharmaEssentia Completes Enrollment for Phase III Primary Myelofibrosis Drug Study | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 1,502 | 1,735.7 | 1,862.11 |
| Spread/Res. | -7.12% | -19.63% | -25.09% |
| Spread/Supp. | +27.40% | +55.17% | +72.22% |
| Support | 1,095 | 899 | 810 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- 6446 Stock
- Charts PharmaEssentia Corporation
Select your edition
All financial news and data tailored to specific country editions
